Recently, we found that baseline levels of osteoprotegerin (OPG), tumor necrosis factor (TNF)-α, interleukin (IL)-6, and CRP levels were associated with adverse cardiovascular outcomes in diabetic patients with PAD and CLTI after LER [17]. The gene discussed is TNF; the disease is peripheral arterial disease.